Related Experiment Video

Updated: May 30, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach

P Vader1, R van der Meel, M H Symons

  • 1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands.

Angiogenesis
|July 27, 2011
PubMed

Insights

Rac1 is crucial for new blood vessel growth in cancer. Silencing Rac1 with RNA interference effectively inhibited tumor angiogenesis and growth, offering a potential anti-cancer strategy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Angiogenesis is a key target in anti-cancer therapy.
  • Vascular endothelial growth factor (VEGF)-mediated angiogenesis is thought to require Rho GTPase Rac1.

Purpose of the Study:

  • To investigate the role of Rac1 in VEGF-mediated angiogenesis using RNA interference.
  • To evaluate the therapeutic potential of Rac1 knockdown in inhibiting tumor growth and angiogenesis.

Main Methods:

  • Human umbilical vein endothelial cells were transfected with Rac1 siRNA or control siRNA.
  • Functional assays assessed the impact of Rac1 knockdown on angiogenesis in vitro (tube formation, migration, invasion, proliferation).
  • In vivo studies included a Matrigel plug assay and intratumoral injection of siRac1 into Neuro2a tumors.

Main Results:

  • Rac1 silencing inhibited VEGF-mediated endothelial cell tube formation, migration, invasion, and proliferation in vitro.
  • Rac1 siRNA treatment suppressed angiogenesis in the Matrigel plug assay.
  • Intratumoral injection of siRac1 significantly inhibited Neuro2a tumor growth and reduced tumor angiogenesis.

Conclusions:

  • Rac1 is a critical regulator of VEGF-mediated angiogenesis.
  • Targeting Rac1 via RNA interference presents a promising strategy for inhibiting tumor angiogenesis and growth.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...